DR. REDDY'S LABORATORIES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,062 INR | -0.64% |
|
+5.80% | +4.58% |
ETFs positioned on Dr. Reddy's Laboratories Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 15 M€ | -4.01% | ||
| 0.01% | 8 M€ | +1.08% | - | |
| 0.00% | 7 M€ | +0.11% | - |
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Sector
Pharmaceuticals
Calendar
2024-07-15
- Détachement de for final dividend
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
35
Last Close Price
6,101
INR
Average target price
6,114
INR
Spread / Average Target
+0.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.58% | 12.16B | |
| +48.39% | 779B | |
| -6.13% | 354B | |
| +20.61% | 333B | |
| +10.00% | 301B | |
| +18.87% | 249B | |
| -1.96% | 216B | |
| +11.11% | 214B | |
| +5.80% | 163B | |
| -2.50% | 159B |
- Stock Market
- Equities
- DRREDDY Stock
- Funds and ETFs Dr. Reddy's Laboratories Limited
